{
  "id": 10405924,
  "title": "Sofinnova Partners closes oversubscribed €82 million MD Start IV fund to build new MedTech startups",
  "url": "https://urgent.news/2026/09/28/sofinnova-partners-closes-oversubscribed-82-million-md-start-iv-fund",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-28T09:05:15.000Z",
  "source": {
    "name": "EU-Startups",
    "slug": "eu-startups",
    "url": "https://www.eu-startups.com/2026/09/sofinnova-partners-closes-oversubscribed-e82-million-md-start-iv-fund-to-build-new-medtech-startups/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Sofinnova Partners, a Paris-based life sciences investor, has successfully closed its Sofinnova MD Start IV fund at €82 million, exceeding its initial target. The fund, which was oversubscribed, will enable the company to continue its strategy of creating MedTech startups from the ground up. Sofinnova Partners, a European venture capital firm specializing in healthcare and sustainability, has backed over 500 companies and manages over €4 billion in assets across seven investment strategies. The MD Start focus on MedTech company creation has yielded notable results, including acquisitions by Inari Medical and Abiomed, and successful Series A funding rounds.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Tech.eu",
        "title": "Sofinnova Partners closes oversubscribed €82M Sofinnova MD Start IV fund",
        "url": "https://urgent.news/2026/09/28/sofinnova-partners-closes-oversubscribed-82m-sofinnova-md-start-iv",
        "published": "2026-09-28T07:10:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}